Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buzzy and EMLA Cream for Vascular Access in Children
NCT04695054Completed
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Mean distress score evaluated by parents. Started Apr 2023; status: completed.
Beyond the preview
Go deeper on NCT04695054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04695054.